by McKesson Ventures | Apr 9, 2024 | Press Releases
On April 9, 2024, CancerIQ’s Founder and CEO Feyi Ayodele was named as one of Modern Healthcare’s Top Innovators of 2024. The list acknowledges innovators that are improving quality and access to care, as well as constantly striving to improve the clinical and...
by McKesson Ventures | Dec 7, 2023 | Press Releases
On Thursday, December 7, 2023, oncology and cancer-health screening company Cancer IQ announced a partnership with the Boston University School of Public Health to study racial and ethnic disparities in genetic counseling and testing for at-risk cancer patients. This...
